Unknown PHASE4 INTERVENTIONAL 2-arm NCT01123538

Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile (ProGEP)

Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression

Sponsor: University Hospital of North Norway

Conditions Pharmacogenomics Systems Biology

Interventions Chlormadinone acetate Progesterone

Updated 5 times since 2017 Last updated: Nov 2, 2011 Started: Dec 31, 2008 Primary completion: Oct 31, 2011 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01123538, this PHASE4 trial focuses on Pharmacogenomics and Systems Biology and remains ongoing. Sponsored by University Hospital of North Norway, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital of North Norway

Data source: University Hospital of North Norway

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bodø, Norway